NEW YORK (GenomeWeb News) — An arbitration panel overseeing a legal skirmish between Digene and Roche has allowed Gen-Probe to participate in the proceeding, Digene said today.

 

In the proceeding, Digene hopes to prove that a February 2005 supply and license agreement between Roche and Gen-Probe was an illegal sublicense under a 1990 cross-license agreement, the rights to which are held by Digene and Roche.